Institutional Biosafety Committee
The Institutional Biosafety Committee (IBC) reviews, approves and provides surveillance of all research protocols involving the use of biohazardous materials including recombinant DNA, agents infectious to humans, animals or plants, and other genetically altered organisms and agents.
|Craig Frank, IBC Chair||Biological Sciences|
|Evon Hekkala||Biological Sciences|
|Qize Wei||Biological Sciences|
|Donald Boyer||Non-affiliated member|
|Joann Casado||Non-affiliated member|
National Institutes of Health Institutional Biosafety Committee